Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.

Hoover LL, Burton EG, O'Neill ML, Brooks BA, Sreedharan S, Dawson NA, Kubalak SW.

Biochim Biophys Acta. 2008 Dec;1783(12):2279-86. doi: 10.1016/j.bbamcr.2008.07.028.

2.

Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.

Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, Karsan A.

J Biol Chem. 2009 Jul 17;284(29):19452-62. doi: 10.1074/jbc.M109.011833.

3.

Requirement of a dynein light chain in TGFbeta/Smad3 signaling.

Jin Q, Gao G, Mulder KM.

J Cell Physiol. 2009 Dec;221(3):707-15. doi: 10.1002/jcp.21910.

4.

Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.

Schwartze JT, Becker S, Sakkas E, Wujak ŁA, Niess G, Usemann J, Reichenberger F, Herold S, Vadász I, Mayer K, Seeger W, Morty RE.

J Biol Chem. 2014 Feb 7;289(6):3262-75. doi: 10.1074/jbc.M113.541052.

5.

Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.

Pedroja BS, Kang LE, Imas AO, Carmeliet P, Bernstein AM.

J Biol Chem. 2009 Jul 31;284(31):20708-17. doi: 10.1074/jbc.M109.018804.

6.
7.

Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.

Nyati S, Schinske K, Ray D, Nyati MK, Ross BD, Rehemtulla A.

Clin Cancer Res. 2011 Dec 1;17(23):7424-39. doi: 10.1158/1078-0432.CCR-11-1248. Erratum in: Clin Cancer Res. 2012 Apr 1;18(7):2115. Nyati, Mukesh [corrected to Nyati, Mukesh K].

8.

Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart.

Wang F, Reece EA, Yang P.

Am J Obstet Gynecol. 2015 May;212(5):650.e1-11. doi: 10.1016/j.ajog.2015.01.014.

9.

Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.

Su CT, Huang JW, Chiang CK, Lawrence EC, Levine KL, Dabovic B, Jung C, Davis EC, Madan-Khetarpal S, Urban Z.

Hum Mol Genet. 2015 Jul 15;24(14):4024-36. doi: 10.1093/hmg/ddv139.

10.

Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.

Akool el-S, Doller A, Müller R, Gutwein P, Xin C, Huwiler A, Pfeilschifter J, Eberhardt W.

J Biol Chem. 2005 Nov 25;280(47):39403-16.

11.

Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.

Zheng Y, Zhao YD, Gibbons M, Abramova T, Chu PY, Ash JD, Cunningham JM, Skapek SX.

J Biol Chem. 2010 Nov 12;285(46):35654-64. doi: 10.1074/jbc.M110.128959.

12.

Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.

Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP, Vanpelt CS, Geng YJ, Deng JM, Behringer RR, de Crombrugghe B.

Arthritis Rheum. 2007 Jan;56(1):334-44.

13.

Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo.

Manser C, Guillot F, Vagnoni A, Davies J, Lau KF, McLoughlin DM, De Vos KJ, Miller CC.

Oncogene. 2012 May 31;31(22):2773-82. doi: 10.1038/onc.2011.437.

14.

p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice.

Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB, Ramirez F.

J Biol Chem. 2009 Feb 27;284(9):5630-6. doi: 10.1074/jbc.M806962200.

15.

Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A.

Mol Cell Biol. 2000 Nov;20(21):8103-11.

16.

Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.

Fan Q, He M, Sheng T, Zhang X, Sinha M, Luxon B, Zhao X, Xie J.

J Biol Chem. 2010 Nov 19;285(47):36570-6. doi: 10.1074/jbc.C110.164442.

17.

Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.

Carvalho RL, Itoh F, Goumans MJ, Lebrin F, Kato M, Takahashi S, Ema M, Itoh S, van Rooijen M, Bertolino P, Ten Dijke P, Mummery CL.

J Cell Sci. 2007 Dec 15;120(Pt 24):4269-77.

18.

C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.

Nakano N, Maeyama K, Sakata N, Itoh F, Akatsu R, Nakata M, Katsu Y, Ikeno S, Togawa Y, Vo Nguyen TT, Watanabe Y, Kato M, Itoh S.

J Biol Chem. 2014 May 2;289(18):12680-92. doi: 10.1074/jbc.M114.558981.

19.

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Kretzschmar M, Doody J, Timokhina I, Massagué J.

Genes Dev. 1999 Apr 1;13(7):804-16.

20.

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.

Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL.

Cell. 1998 Dec 11;95(6):779-91.

Items per page

Supplemental Content

Support Center